Orasis Pharmaceuticals
Corrective Eye Drops for Presbyopia
StartupOrasis Pharmaceuticals is a Herzliya-based startup in the Health Tech & Life Sciences sector, established in 2015. Corrective Eye Drops for Presbyopia. The company has raised a total of $121M across 5 funding rounds, currently at the D stage. Key investors include Arboretum Ventures, Visionary Ventures, Bluestem Capital, among 12 total investors. The company has 51-200 employees.
With $121M in total funding, Orasis Pharmaceuticals is a D-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released. The company holds 1 patent.
- StageD
- ProductReleased
- ModelB2B
- Employees51-200
- HQHerzliya
- DistrictCenter District
- Last Round$78M
- Arboretum VenturesLead
- Visionary Ventures
- Bluestem Capital
12 investors total
15 articles covered by sources including www.visionmonday.com,
www.prnewswire.com,
www.globenewswire.com,
en.globes.co.il,
www.healio.com.
What does Orasis Pharmaceuticals do?
Orasis is an emerging ophthalmic pharmaceutical company with an FDA approved prescription eye drop, QLOSI™ (pilocarpine HCl ophthalmic solution) 0.4%, for presbyopia as an alternative to reading glasses. Presbyopia is the gradual loss of your eye’s ability to focus on near objects, which begins to affect most people sometime after the age of 40 and affects more than 1.8 billion people worldwide. Orasis is led by a collaborative team of industry executives, Optometrists and Ophthalmologists with a diverse set of experiences in research, development, and commercialization of pharmaceutical drugs, as well as finance and business development.
How much funding has Orasis Pharmaceuticals raised?
Orasis Pharmaceuticals has raised $121M in total funding across 5 rounds. The company is currently at the D stage. Key investors include Arboretum Ventures, Visionary Ventures, Bluestem Capital.
What sector is Orasis Pharmaceuticals in?
Orasis Pharmaceuticals operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is Orasis Pharmaceuticals located?
Orasis Pharmaceuticals is based in Maskit St 6, Herzliya, Israel, Center District. The company also has offices abroad.